France eliminates clinical trial application fees
This article was originally published in SRA
Executive Summary
Researchers in France no longer have to pay fees to register clinical trials with AFSSAPS, the national medicines regulator1. A provision in the country’s budget for this year took effect on 1 January, eliminating two fees that cost sponsors up to €6,000 per trial application. The changes are aimed at simplifying procedures.